Skip to main content

Succinic Semialdehyde Dehydrogenase Deficiency Presenting as Autism Spectrum Disorder

The Indian Journal of Pediatrics volume 83, pages 1036–1037 (2016)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Gahr M, Connemann BJ, Schönfeldt-Lecuona CJ, Freudenmann RW. Succinic semialdehyde dehydrogenase deficiency: an inheritable neurometabolic disease. Fortschr Neurol Psychiatr. 2013;81:154–61.

    CAS  Article  PubMed  Google Scholar 

  2. Acosta MT, Munasinghe J, Pearl PL, et al. Cerebellar atrophy in human and murine succinic semialdehyde dehydrogenase deficiency. J Child Neurol. 2010;25:1457–61.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Schiff M, Benoist JF, Aïssaoui S, et al. Should metabolic diseases be systematically screened in nonsyndromic autism spectrum disorders? PLoS ONE. 2011;6:e21932.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  4. Spilioti M, Evangeliou AE, Tramma D, et al. Evidence for treatable inborn errors of metabolism in a cohort of 187 Greek patients with autism spectrum disorder (ASD). Front Hum Neurosci. 2013;7:858.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Ghaziuddin M, Al-Owain M. Autism spectrum disorders and inborn errors of metabolism: an update. Pediatr Neurol. 2013;49:232–6.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Special acknowledgements to Dr. Gajja Salomons, Department of Clinical Chemistry, Metabolic Unit, VU University Medical Center, Amsterdam, The Netherlands, for analysis of the ALDH5A1 gene.

Author information

Affiliations

  1. 4th Department of Pediatrics, School of Medicine, Aristotle University of Thessaloniki, General Hospital Papageorgiou, Thessaloniki, Greece

    Maria Gogou, Despoina Tramma, Efimia Papadopoulou-Alataki & Athanasios Evangeliou

  2. 1st Department of Neurology, Aristotle University of Thessaloniki, University General Hospital AHEPA, Thessaloniki, Greece

    Martha Spilioti

  3. Dimitriou Nika 44, 60, 100, Katerini, Greece

    Maria Gogou

Authors
  1. Maria Gogou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martha Spilioti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Despoina Tramma
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Efimia Papadopoulou-Alataki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Athanasios Evangeliou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria Gogou.

Ethics declarations

None.

Source of Funding

None.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Gogou, M., Spilioti, M., Tramma, D. et al. Succinic Semialdehyde Dehydrogenase Deficiency Presenting as Autism Spectrum Disorder. Indian J Pediatr 83, 1036–1037 (2016). https://doi.org/10.1007/s12098-015-2003-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-015-2003-0

Keywords

  • Autism Spectrum Disorder
  • Taurine
  • Intellectual Disability
  • Vigabatrin
  • Sodium Valproate